Drug intelligence / Profile preview

Omegaflex Special

Development stage
Unknown
Lead developer
B. Braun
Modality
Peptides, Small Molecules
Administration
Intravenous, Parenteral
01

Overview

Omegaflex Special is a multi-chamber emulsion for intravenous infusion used in parenteral nutrition. It is specifically indicated for adult patients in states of moderate to severe catabolism when oral or enteral nutrition is impossible, insufficient, or contraindicated. The product is designed as a three-chamber bag system: one chamber contains an amino acid solution with electrolytes, the second contains a glucose solution, and the third contains a lipid emulsion. The lipid component is a blend of omega-3-acid triglycerides (derived from fish oil), soybean oil (providing omega-6 fatty acids), and medium-chain triglycerides (MCT). This formulation provides a balanced supply of energy, essential fatty acids, and nitrogen to support metabolic needs and protein synthesis. In clinical research, it is being evaluated for its potential to support liver function recovery in critically ill patients suffering from parenteral nutrition-associated liver impairment, leveraging the anti-inflammatory properties of its omega-3 content.

Brand names
Omegaflex Special
Other names
Omegaflex Special emulsion for infusion

Beyond the preview

Go deeper on Omegaflex Special.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omegaflex Special.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call